JeffreysCarlinMD
Rheumatology • Seattle, WALupus & Related, Rheumatoid Arthritis & Related, Scleroderma & Related, Vasculitis
Clinical Associate Professor, Rheumatology Inpatient Consult Service University of Washington
Dr. Carlin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 NE Pacific St Suite BB561
Seattle, WA 98195Phone+1 206-992-0585
Summary
- Dr. Jeffrey Carlin is a rheumatologist in Seattle, WA and is affiliated with the University of Washington. He previouysly was the Director of the Rheumatology Division at Virginia Mason Medical Center. He received his medical degree from NYU School of Medicine and has been in practice 44 years. He specializes in lupus & related, rheumatoid arthritis & related, scleroderma & related, and vasculitis.
Education & Training
- University of WashingtonFellowship, Rheumatology, 1978 - 1980
- Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 1975 - 1978
- New York University School of MedicineClass of 1975
Certifications & Licensure
HI State Medical License 2023 - 2026
WA State Medical License 1978 - 2026
WI State Medical License 1976 - 1978
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014-2019
- CMS Meaningful Use Stage 1 Certification HealthSentry EHR, Cerner Corporation, 2013
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension Start of enrollment: 2017 Jan 01
- KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis Start of enrollment: 2019 Jun 26
- Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3) Start of enrollment: 2019 Oct 14
Publications & Presentations
PubMed
- 1 citationsAntigen-specific T-cell frequency and phenotype mirrors disease activity in DRB1*04:04+ rheumatoid arthritis patients.Cliff Rims, Hannes Uchtenhagen, Kadin Brooks, Bernard Ng, Sylvia E Posso
Clinical and Experimental Immunology. 2025-01-21 - T cells promote distinct transcriptional programs of cutaneous inflammatory disease in keratinocytes and dermal fibroblasts.Hannah A DeBerg, Mitch L Fahning, Suraj R Varkhande, James D Schlenker, William P Schmitt
Biorxiv. 2024-12-22 - 18 citationsSARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity.Jillian R Jaycox, Carolina Lucas, Inci Yildirim, Yile Dai, Eric Y Wang
Nature Communications. 2023-03-09
Journal Articles
- Citrullinated Aggrecan Epitopes as Targets of Auto‐Reactive CD4+ T Cells in Patients with Rheumatoid ArthritisJeffrey Carlin, Jane H Buckner, Eddie A James, Mariana J Kaplan, Arthritis & Rheumatology
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
